Children With Aluminium Contact Allergy: Oral Exposure Study

NCT ID: NCT04921163

Last Updated: 2023-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2022-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aluminium allergy is predominantly seen in children with small itchy nodules in the skin after vaccinations, so-called granulomas. We want to do an exposure study where aluminium allergic children have to eat aluminium pancakes for a short period of time. The purpose is to investigate whether a worsening of the children's symptoms can be detected, both itching of the granuloma, allergic rash on the skin and also the symptoms that are not measurable, such as headache, stomach ache and general agitation. We also want to examine the concentration of aluminium in the urine, which reflects the absorption of aluminum from the gastrointestinal tract.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Parents of aluminium allergic children have reported that children may react with increased itching of their granulomas, skin symptoms in the form of redness, itching and rash, as well as symptoms such as headache, abdominal pain and agitation, by ingesting aluminium-containing foods.

Children are predominantly exposed to aluminium via the diet as they do not yet use aluminium-containing cosmetic products, stomach acid medicines or deodorants. The amount of aluminium in children's diet varies between 0.22-0.90 mg/kg body weight/week, depending on their age. In older children and adults, the intake is less related to the aluminium in infant formula, breakfast cereals and dried fruit, which is consumed more by children than adults.

With this study, we want to create an exposure study where children have to eat pancakes for a limited period of time, where aluminium has been used as baking soda, and for two control periods eat pancakes without aluminium.

Any symptoms occurring during periods could be used to investigate whether children with aluminium allergies generally react after intake of aluminium-containing foods and whether as such it is a consequential condition in some children or whether it is isolated cases. It is a very important issue to clarify with a view to proper advice, both with regard to the possible avoidance of specific foods and in the case of future vaccinations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Dermatitis Contact Allergy Aluminum Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

double blinded cross over study
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aluminium

4-day test periode with intake of aluminium pancakes

Group Type ACTIVE_COMPARATOR

sodium aluminium phospate (SALP)

Intervention Type DIETARY_SUPPLEMENT

1 pancake daily for 4 days

placebo

4-day test periode with aluminium-free pancakes

Group Type PLACEBO_COMPARATOR

Aluminium-free pancake

Intervention Type DIETARY_SUPPLEMENT

1 pancake daily for 4 days, without aluminium

second placebo

Again a 4-day test periode with aluminium-free pancakes

Group Type PLACEBO_COMPARATOR

Aluminium-free pancake

Intervention Type DIETARY_SUPPLEMENT

1 pancake daily for 4 days, without aluminium

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sodium aluminium phospate (SALP)

1 pancake daily for 4 days

Intervention Type DIETARY_SUPPLEMENT

Aluminium-free pancake

1 pancake daily for 4 days, without aluminium

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with contact allergies to aluminium, demonstrated by patch tests
* Activity (itching) of the granulom within the last six months
* Written consent obtained from all custodians

Exclusion Criteria

* a detected food allergy for the remaining products in the pancakes (including wheat flour, eggs and milk)
* Children treated with topical and/or systemic steroid preparations during and up to 1 week before the start of the study.
* Children treated with systemic immune suppression during and up to 1 week before the start of the study.
* Children with kidney or bone disease.
* Children vaccinated during the study period
* Treatment with acid neutralising medicines during and up to 1 week before the start of the study
* Another reason for inability to cooperate, including lack of language skills in Danish or English in parents.
Minimum Eligible Age

1 Year

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Allergy Research Center, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stine Hoffmann

MD, ph.d. student

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Allergy Research Centre

Hellerup, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-20060917

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Food Oral Immunotherapy for Peanut Allergy
NCT04222491 ENROLLING_BY_INVITATION PHASE2
Tolerance Following Peanut Oral Immunotherapy
NCT01750879 COMPLETED PHASE1/PHASE2